
Macarena Hernández Jiménez
@makimhj
Neuroscience, Biomedicine, Pharmacology, Clinical Trials
ID: 1484619738290470917
21-01-2022 20:11:53
82 Tweet
101 Takipçi
243 Takip Edilen

In San Francisco for the J.P. Morgan Healthcare Conference week! #JPM24 #ApTOLL #DrugDevelopment #neuroprotection #AcuteIschemicStroke #AcuteMyocardialInfarction


Our CSO Macarena Hernández (Macarena Hernández Jiménez) will speak at the 10th European #Stroke Conference next May 15 in Basel. Join us to discover “Tackling the Inflammation: The #APRIL group”. 🕓 3:50 pm 📍 Basel - Room Boston ℹ️ bit.ly/44tCnpm #ESOC2024 #ApTOLL #cytoprotection



Preclinical studies validate the potential of #ApTOLL developed by aptaTargets to reduce inflammation and regenerate myelin in models of #MultipleSclerosis. Results published in British Journal of Pharmacology (BJP): bit.ly/3WPkbF4





Un año más, comenzamos con ilusión el Título de Especialista en Intervenciones Asistidas con Caballos. Siempre hacia una mejora en la calidad de vida de los pacientes #IACs #rehabilitación #ictus Complutense FVeterinariaUCM


Hoy la Doctora Fernández defendía su tesis doctoral tras 5 años de duro trabajo en los que he tenido la fortuna de participar con los mejores Fernando de Castro S aptaTargets Espero que hayas aprendido de mí tanto como yo de ti, Bea.


Always good news to see a #PhD_thesis that you directed receiving the #CumLaude calification...! Congrats to brand-new doctor #BeatrizFernándezGómez (Instituto Cajal-Centro de Neurociencias Cajal-CSIC aptaTargets),co-director Dr. #MacarenaHernández & the rest of people+institutions (Comunidad de Madrid UAM Autónoma Madrid)



Next week we are busy in #RICORSICTUS🧠 We gather at🏥Vall d'Hebron Institut de Recerca hosted by Neurovascular Research Lab (VHIR) for: - our 3rd Annual Congress, sharing the results of our cooperative #research (Tue 8-Wed 9) 🧑🔬 - a Symposium on Intracerebral Hemorrhage (Mon 7 - Tue 8)👩🏫 The program 👉dropbox.com/s/anispu782qzl…






Más presentaciones de proyectos colaborativos en distinto grado de desarrollo: -Israel Fernandez de Stroke Pharmacogenomics and Genetics Institut de Recerca Sant Pau -Macarena Hernández Jiménez de @neurovasculab del i+12 -Manuel Navarro-Oviedo del mismo grupo -Mikel Terceño de Unitat d'Ictus Girona Hospital Trueta




#ApTOLL’s secondary analysis data of APRIL 1b/2a trial published in scientific journal “Stroke” from American Heart Association: aptatargets.com/newsroom/aptol… #stroke #AcuteIschemicStroke #cerebroprotection
